SCHEMBL14744909

SCHEMBL14744909

O=C1CC(c2ccnnc2)=Nc2ccccc2N1

nearest known ligand 0.69

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.69
TP53 P04637 1/20 0.54
SMN1; SMN2 Q16637 3/20 0.50
RAB9A P51151 2/20 0.50
NPC1 O15118 2/20 0.47
GRM2 Q14416 2/20 0.46
MAPT P10636 5/20 0.46
LMNA P02545 2/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
KDM4E B2RXH2 1/20 0.46
HTT P42858 1/20 0.46
CASP3 P42574 1/20 0.46
SENP8 Q96LD8 1/20 0.46
SENP7 Q9BQF6 1/20 0.46
SENP6 Q9GZR1 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16394950 0.85 RAB9A (0.59) ALDH1A1SMN1; SMN2RAB9ANPC1GRM2
SCHEMBL1420797 0.82 ALDH1A1 (1.00) ALDH1A1TP53SMN1; SMN2RAB9ANPC1
SCHEMBL14744648 0.82 GRM2 (0.64) ALDH1A1SMN1; SMN2RAB9ANPC1GRM2
SCHEMBL14744633 0.82 GRM2 (0.66) ALDH1A1SMN1; SMN2RAB9ANPC1GRM2
SCHEMBL14744793 0.82 GRM2 (0.52) ALDH1A1SMN1; SMN2RAB9AGRM2
SCHEMBL23954519 0.82 RAB9A (0.69) ALDH1A1SMN1; SMN2RAB9ANPC1GRM2
SCHEMBL14744721 0.82 RAB9A (0.49) SMN1; SMN2RAB9AGRM2
SCHEMBL14744704 0.82 GRM2 (0.55) ALDH1A1SMN1; SMN2RAB9ANPC1GRM2
SCHEMBL14744661 0.82 RAB9A (0.49) ALDH1A1SMN1; SMN2RAB9ANPC1GRM2
SCHEMBL16395290 0.81 GRM2 (0.54) GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2751095-A2 NOVEL BENZODIAZEPINONES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR FUNCTIONS AND NEUROLOGICAL USES THEREOF Sanford-Burnham Medical Research Institute (US) 2014-07-09 EP disclosed
WO-2013033246-A2 NOVEL BENZODIAZEPINONES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR FUNCTIONS AND NEUROLOGICAL USES THEREOF BRAINCELLS, INC. (US) 2013-03-07 WO disclosed